ECOR

electroCore, Inc. (ECOR) | Rumor.io

electroCore

ECOR

Attention (50-day avg)0%

Attention rank (50-day avg)#2,027

Bullish sentiment (50-day avg)96%

Price to earnings ratio-6.7

Market capitalization99.4M

Earnings per share-1.65

Dividend yield (TTM)—

Revenue (annual)32M

Net income (annual)-14M

Social

What share of all stock conversation is about ECOR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% +0

May 26

$ECOR has been surging, up around 26% to over $8.00, after opening at $6.79, following a Q1 revenue beat of $9.6M, up 43% YoY.
Insider buying has been observed, with Errico Thomas J., Director, purchasing 9,992 shares for $59.85K on May 21.
$ECOR has broken a short-term downtrend and is poised to cross over its 20-month MA, with some analysts predicting a further upswing of 20-25%.

Generated by AI

Sentiment

Of the messages about ECOR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% 0	100% +8.62	99.75% +9.8
Bearish	—	0% 0	0% -8.62	0.25% -9.8

Bullish· Nov 13

$ECOR has announced that Truvaga will be sold on Amazon, potentially driving significant revenue growth.
The company has reported strong revenue growth of 45% YoY, with demand for its Rx gamma core and Truvaga solutions continuing to drive robust growth.
The company is expected to turn profitable in a couple of quarters, with operating leverage helping to reduce net losses and increase profitability.

Bearish· Jan 19

The management of electroCore, Inc. has been accused of prioritizing their own interests over those of shareholders, including conducting offerings that harm the company's share price.
The company's short interest has been decreasing, but this has been accompanied by a drop in price, suggesting that the trend may continue.
The company's technical indicators, such as its chart pattern, suggest a continued decline in its stock price.

Generated by AI

Topics

Of the messages about ECOR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	89.47%	2.76%
Macro	—	0%	7.89%	48.58%
Earnings	—	0%	2.63%	0.09%
Analysts	—	0%	0%	48.43%
Controversies	—	0%	0%	0.01%
Technical Analysis	—	0%	0%	0.14%

Announcements· Nov 2

electroCore, Inc. (ECOR) has partnered with Joerns Healthcare, LLC to expand the use of gammaCore(TM) vagus nerve technology for headache sufferers.
The partnership aims to make gammaCore more widely available for the treatment of migraines and other headache disorders.
The distribution agreement is expected to increase access to electroCore's non-invasive, non-pharmacologic treatment for acute and episodic migraines.

Technical Analysis· Mar 1

$ECOR has decent support from the 3.35-3.40 area and could pull back to 4 for the longer uptrend.
The stock's recent movement has been driven by volume, with some traders expecting a big run if it breaks the 3.30 area.
Technical indicators such as the MACD and RSI are currently cooling off, indicating the stock may be oversold and due for a dip.

Generated by AI

Community

Of the messages about ECOR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	59.26%	70.15%	5.2%
Newcomers	—	40.74%	29.85%	94.8%

Regulars· Feb 18

The regulars are optimistic about electroCore, Inc. ($ECOR) with one investor describing it as a "3 bagger" since their first buy.
The company is expanding its sales team from 100 to 200 people, with these contractors being heavily compensated based on sales brought in, potentially leading to increased revenue.
electroCore, Inc. ($ECOR) is expected to see a significant shift in its revenue streams, with coal exposure decreasing to less than 20% in three years and copper exposure increasing to over 500k tonnes.

Newcomers· Dec 29

New to discussing $ECOR, the user notes that it looks "compelling" with "inflections imminent", implying they see potential for growth.
The user compares $ECOR to $PSIX, suggesting they are considering the two assets together and thinking about the potential for $ECOR to outperform $PSIX.
The user expresses uncertainty about holding $ECOR due to a lack of knowledge about the medical device market, highlighting a concern about the company's industry.

Generated by AI

electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

11d agoYahoo Finance

Full Transcript: electroCore Q2 2026 Earnings Call

12d agoBenzinga

electroCore to Participate at H.C. Wainwright Global Investment Conference

ROCKAWAY, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel. On Tuesday, September 15, 2026, Joshua Lev, Co-CEO, President and CFO, will participate in a fireside chat and host one-on-one meetings with investors during the conference. Investors who wish to reques

19d agoYahoo Finance

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Internal leadership appointments reflect the Company's confidence in two exceptional leaders whose complementary strengths will enhance shareholder valueROCKAWAY, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company and leader in non-invasive vagus nerve stimulation technologies, today announced that it has appointed Joshua Lev and Mike Fox as Co-Chief Executive Officers and members of the Board of Directors, ef

20d agoYahoo Finance

Also Discussed

Investors talking about ECOR also mention

#	Name	Attention
1	Crexendo Inc.CXDO	0%0
2	VirTra, Inc.VTSI	0%0
3	Boxlight Corporation Class A Common StockBOXL	0%new
4	WHLM - Wilhelmina International, Inc.	——
5	Equillium Inc.EQ	0%0
6	EMX - EMX Royalty Corporation	——
7	Valor Energy Inc.AIHS	0%new
8	Edesa Biotech, Inc.EDSA	0%new
9	VCNX - Vaccinex, Inc.	——
10	ALRN - Aileron Therapeutics, Inc.	——

electroCore, Inc.

Healthcare
Medical Devices

electroCore, Inc. is a commercial-stage bioelectronic medicine company that develops non-invasive vagus nerve stimulation (nVNS) products for healthcare and wellness use. Its core offerings include gammaCore, a prescription handheld device used for primary headache conditions such as migraine and cluster headache, as well as Quell Fibromyalgia for chronic pain management. The company also markets Truvaga and TAC-STIM, consumer-focused nVNS products designed to support general wellness and human performance. electroCore’s technology platform is built around non-invasive neuromodulation, with products intended for both clinical and personal use across the United States, the United Kingdom, and international markets. Headquartered in Rockaway, New Jersey, electroCore serves a growing role in the medical device and bioelectronic therapy sectors by offering portable, non-surgical alternatives that address pain, wellness, and performance-related needs.

Website

Location

200 Forge Way

Rockaway, NJ, 07866

United States

Social

What share of all stock conversation is about ECOR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% +0

May 26

$ECOR has been surging, up around 26% to over $8.00, after opening at $6.79, following a Q1 revenue beat of $9.6M, up 43% YoY.
Insider buying has been observed, with Errico Thomas J., Director, purchasing 9,992 shares for $59.85K on May 21.
$ECOR has broken a short-term downtrend and is poised to cross over its 20-month MA, with some analysts predicting a further upswing of 20-25%.

Generated by AI

Sentiment

Of the messages about ECOR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% 0	100% +8.62	99.75% +9.8
Bearish	—	0% 0	0% -8.62	0.25% -9.8

Bullish· Nov 13

$ECOR has announced that Truvaga will be sold on Amazon, potentially driving significant revenue growth.
The company has reported strong revenue growth of 45% YoY, with demand for its Rx gamma core and Truvaga solutions continuing to drive robust growth.
The company is expected to turn profitable in a couple of quarters, with operating leverage helping to reduce net losses and increase profitability.

Bearish· Jan 19

The management of electroCore, Inc. has been accused of prioritizing their own interests over those of shareholders, including conducting offerings that harm the company's share price.
The company's short interest has been decreasing, but this has been accompanied by a drop in price, suggesting that the trend may continue.
The company's technical indicators, such as its chart pattern, suggest a continued decline in its stock price.

Generated by AI

Topics

Of the messages about ECOR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	89.47%	2.76%
Macro	—	0%	7.89%	48.58%
Earnings	—	0%	2.63%	0.09%
Analysts	—	0%	0%	48.43%
Controversies	—	0%	0%	0.01%
Technical Analysis	—	0%	0%	0.14%

Announcements· Nov 2

electroCore, Inc. (ECOR) has partnered with Joerns Healthcare, LLC to expand the use of gammaCore(TM) vagus nerve technology for headache sufferers.
The partnership aims to make gammaCore more widely available for the treatment of migraines and other headache disorders.
The distribution agreement is expected to increase access to electroCore's non-invasive, non-pharmacologic treatment for acute and episodic migraines.

Technical Analysis· Mar 1

$ECOR has decent support from the 3.35-3.40 area and could pull back to 4 for the longer uptrend.
The stock's recent movement has been driven by volume, with some traders expecting a big run if it breaks the 3.30 area.
Technical indicators such as the MACD and RSI are currently cooling off, indicating the stock may be oversold and due for a dip.

Generated by AI

Community

Of the messages about ECOR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	59.26%	70.15%	5.2%
Newcomers	—	40.74%	29.85%	94.8%

Regulars· Feb 18

The regulars are optimistic about electroCore, Inc. ($ECOR) with one investor describing it as a "3 bagger" since their first buy.
The company is expanding its sales team from 100 to 200 people, with these contractors being heavily compensated based on sales brought in, potentially leading to increased revenue.
electroCore, Inc. ($ECOR) is expected to see a significant shift in its revenue streams, with coal exposure decreasing to less than 20% in three years and copper exposure increasing to over 500k tonnes.

Newcomers· Dec 29

New to discussing $ECOR, the user notes that it looks "compelling" with "inflections imminent", implying they see potential for growth.
The user compares $ECOR to $PSIX, suggesting they are considering the two assets together and thinking about the potential for $ECOR to outperform $PSIX.
The user expresses uncertainty about holding $ECOR due to a lack of knowledge about the medical device market, highlighting a concern about the company's industry.

Generated by AI

electroCore

Social

May 26

Bullish· Nov 13

Bearish· Jan 19

Announcements· Nov 2

Technical Analysis· Mar 1

Regulars· Feb 18

Newcomers· Dec 29

electroCore Has A Line Of Sight At Cash Breakeven (NASDAQ:ECOR)

electroCore president Michael Fox purchases $49,003 in company stock

electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?

Full Transcript: electroCore Q2 2026 Earnings Call

electroCore to Participate at H.C. Wainwright Global Investment Conference

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Also Discussed

electroCore, Inc.

Company Information

Location

electroCore Has A Line Of Sight At Cash Breakeven (NASDAQ:ECOR)

electroCore president Michael Fox purchases $49,003 in company stock

electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?

Full Transcript: electroCore Q2 2026 Earnings Call

electroCore to Participate at H.C. Wainwright Global Investment Conference

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Also Discussed

Social

May 26

Bullish· Nov 13

Bearish· Jan 19

Announcements· Nov 2

Technical Analysis· Mar 1

Regulars· Feb 18

Newcomers· Dec 29